Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07419425
RecruitingNCT07419425ClinicalTrials.gov record

My Path to Quit Tobacco

Smoking Cessation

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Interventional
Phase
Phase 4
Age range
21 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
1550 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.

Read the full description

Primary Objective: Identify the most effective treatment for increasing long-term smoking abstinence among Black adults who smoke.

Secondary Objectives:

  • Compare the 3 interventions on key patient-relevant outcomes (e.g., treatment satisfaction, smoke fewer cigarettes per day, quality of life) using validated measures collected at 8 and 26 weeks post-target quit day (TQD)
  • Identify subgroups for whom these treatments are especially effective or ineffective with respect to the primary and secondary outcomes.
  • Compare indices of treatment engagement (e.g., percentage of counseling sessions attended, percentage of days used nicotine patch) among Black people who smoke and are randomly assigned to the 3 different treatment conditions.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • self-identify as Black
  • smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)
  • motivated to quit smoking
  • willing to discontinue any non-study smoking cessation pharmacotherapy use during study treatment.

Exclusion Criteria:

  • currently taking bupropion for non-smoking cessation reasons
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Random assignment
Masking
Single masked
Standard Intervention

The Standard Intervention will include 2 weeks of nicotine patches + 4 quitline-style counseling phone calls.

Drug: Nicotine patch · Other: Quitline Counseling Phone Calls

Intensive Intervention

The Intensive Intervention will include 8 weeks of nicotine patches (if eligible) + 8 counseling sessions (choice of individual phone or virtual group) + the Pathways to Freedom video content on the study website with additional smoking cessation content.

Drug: Nicotine patch · Other: Counseling Sessions · Other: Pathways to Freedom

Intensive Incentivized Intervention

The Intensive Incentivized Intervention will include all components provided in the Intensive intervention (8 weeks of nicotine patches (if eligible) + 8 counseling sessions (choice of individual phone or virtual group) + the Pathways to Freedom video content on the study website with additional smoking cessation content) and up to $50 for completing counseling sessions ($5 for completing sessions 1-6 and $10 for completing sessions 7 and 8)

Drug: Nicotine patch · Other: Counseling Sessions · Other: Pathways to Freedom · Other: Monetary Incentive

Nicotine patch DRUG

Patch dosing will be consistent with the package insert

Quitline Counseling Phone Calls OTHER

4, 10 to 15-minute counseling sessions (the duration of a typical quitline call) will occur via phone one week prior to the TQD, 1 day after the TQD, and 1 and 2 weeks after the TQD.

Counseling Sessions OTHER

Participants will have the option of choosing 8, 30-minute counseling phone calls or 8, 60-minute video group counseling sessions

Pathways to Freedom OTHER

Pathways to Freedom video content, a 60-minute video that addresses key issues such as emotional dependence, nicotine replacement, identifying smoking triggers, developing coping skills, and other behavioral strategies people can use to support a quit attempt.

Monetary Incentive OTHER

up to $50 for completing counseling sessions ($5 for completing sessions 1-6 and $10 for completing sessions 7 and 8)

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day

Time frame: 26 weeks post-TQD

The primary outcome for this study will be biochemically confirmed (anabasine less than 2 ng/ml) 7-day point-prevalence smoking abstinence at 26- weeks post-TQD

Secondary measures

Biochemically confirmed abstinence from any nicotine product at 26-weeks post-target quit day

Time frame: 26 weeks post-TQD

salivary cotinine using a cut-off of less than 10 ng/ml to indicate abstinence from any nicotine product (combusted cigarettes, e-cigarettes, nicotine replacement therapy \[NRT\])

Treatment Satisfaction

Time frame: 8 weeks post-TQD

Scored from 1 to 7 where higher scores indicate increased satisfaction with treatment.

Cigarettes per day

Time frame: baseline, 8 and 26 weeks post-TQD

Cigarettes per day based on the past 7 days.

Quality of Life measured by the Medical Outcomes Study's 12-item Short Form Survey Instrument (SF-12)

Time frame: baseline, 8 and 26 weeks post-TQD

Scores range from 0 to 100 where higher scores indicate better quality of life.

Money spent on cigarettes per week

Time frame: baseline, 8 and 26 weeks post-TQD

Not reported in this registry record.

Smoking Cessation Self-efficacy using a single 10-point Likert scale

Time frame: baseline, 8 and 26 weeks post-TQD

Scores range from 1 to 10 where higher scores mean higher cessation self-efficacy.

Psychological Distress measured by the 6-item Kessler screener (K6)

Time frame: baseline, 8 and 26 weeks post-TQD

Total range of scores is from 0-24 where higher scores mean decreased psychological distress.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (5)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

5 locations

Arizona State UniversityPhoenix, Arizona, United StatesNot yet recruiting
Indiana UniversityIndianapolis, Indiana, United StatesNot yet recruiting
University of Kansas Medical Center Research Institute, IncKansas City, Kansas, United StatesNot yet recruiting
Virginia Commonwealth UniversityRichmond, Virginia, United StatesNot yet recruiting
UW School of Medicine and Public HealthMilwaukee, Wisconsin, United StatesRecruiting

Study team and timeline

Lead sponsor
University of Wisconsin, Madison
Study start
Jul 6, 2026 Actual
Primary completion
2030-01 Estimated
Study completion
2030-01 Estimated
First posted
Feb 19, 2026 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

Megan Piper, PhDCONTACTmep@ctri.wisc.edu608-265-5472
Official study title

Comparing Three Multicomponent Interventions to Help Adults Quit Smoking

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026